To confirm the role of ER stress as a likely mechanism for RUNX1 imparting GEM resistance, we then evaluated whether chemically targeting ER stress could reverse the response of pancreatic cancer cells to GEM. This evidence concerns the gene RUNX1 and pancreatic neoplasm.